Yaohai: A company that produces medicine for the sick. Recombinant FGF is a vital medicine they produce. FGF is a specific type of protein that is important for recovery of healing in your body. Yaohai is constantly looking for better ways to create medicine that can be even more helpful to people. They are committed to advancing the health of human beings through technology.
In Yaohai, the scientists laboriously create Recombinant FGF in the laboratory. In this lab, they are using special cells — they act like little factories. These cells make the FGF. The Yaohai scientists have a new way to boost the levels of FGF that these cells make. They use a special machine, called a bioreactor, to help the cells grow and produce even more FGF. “This machine provides the ideal setup to grow the cells and make the all-important protein for healing.
One of the interesting techniques they are investigating is using cells that are not human. These other types of cells can produce more FGF than those derived from humans. The researchers have even figured out a way to make the equivalent FGF from these cells function just the same as the FGF in humans. In other words, the medicine derived from these cells is even more effective at enabling people to heal and recover from their diseases or injuries.
When we say producing a lot of medicine, we’re talking about the capacity to help many people at once. Yaohai has made a huge effort to prepare for large scale production of Recombinant FGF. They have purchased large machines and have collected a large number of ready-to-use cells. Then they are prepared to serve a greater number of patients who require their medicine.
But it's more than just pumping out lots of medicine. Yaohai is also extremely worried about the safety and efficacy of the medicine they produce. They conduct tests on every batch of medicine to ensure it contains the correct amount of FGF. They also ensure that there is no contamination with toxic substances or other drugs that might threaten people.
Yaohai has figured out how to maximize the amount of FGF they can get from each batch of cells. They also employ a special process called chromatography. This is the process that allows them to isolate all the various components of the medicine. This leaves the FGF as the sole vector within the end product, thus avoiding contamination and background noise to the medicine.
One other new thing they are doing with Recombinant FGF is helping people who have issues with their bones. FGF can stimulate bones to grow at higher speed and repair more effectively Yaohai is developing a method to inject Recombinant FGF directly into the bone, which will promote healing and recovery in people with bone-related concerns.
Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have built an advanced facility that is equipped with advanced facilities as well as robust RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and fermentation along with two automated fill and finishing lines for vials, cartridges and needles pre-filled are available. The scales for fermentation available are 100L, 500L, 1000L and 2000L. The filling volume ranges from 1ml to Recombinant FGF Manufacturing. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production workshop ensures steady supply of clinical samples and commercial products. The bulk molecules produced in our factory can be shipped worldwide.
Yaohai BioPharma, a top 10 Microbial CDMO that integrates quality management and regulatory affairs. Our quality system that is compliant with current GMP standards as well as international regulations. Our team of regulatory experts is proficient in global regulatory frameworks to accelerate biological launches. We ensure traceable production procedures quality products, as well as conformity with the requirements of the Recombinant FGF Manufacturing and EU EMA. Australia TGA and China NMPA are also met. Yaohai BioPharma successfully passed an in-person audit conducted by a Qualified Person of the European Union (QP) to examine our GMP system and production facility. We also completed the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.
Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to manage the health of pets, humans and animals. health. We have modern RD and manufacturing technology platforms that cover the entire process, from microbial strain engineering, cell banking, process and method design to commercial and clinical manufacturing, which ensures the success supply of the most cutting-edge solutions. Through the years we have gained vast expertise in using microbial sources. Over 200 projects were successfully completed. In addition, we support our clients in get through regulations, such as those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. Our expert knowledge and vast experience allow us to quickly respond to market demands and provide Recombinant FGF Manufacturing CDMO services.
Yaohai Bio-Pharma is experienced in the development of microbial-derived biologics We offer tailored RD solutions and manufacturing while keeping risks to a minimum We have used a variety of modalities including recombinant subunits vaccines (including peptides) growth factors hormones and Cytokines We've specialized in several microorganisms like yeast intracellular and extracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion body (yields as high as 10g/L) We have also created a Recombinant FGF Manufacturing fermentation system to develop bacteria-based vaccines We are experts in optimizing processes increasing yields as well as reducing production costs Utilizing a strong technology team we ensure timely and quality project delivery to bring your exclusive products to market faster